BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 16855189)

  • 1. Elevated serum monocyte chemoattractant protein-4 and chronic inflammation in overweight subjects.
    Hashimoto I; Wada J; Hida A; Baba M; Miyatake N; Eguchi J; Shikata K; Makino H
    Obesity (Silver Spring); 2006 May; 14(5):799-811. PubMed ID: 16855189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters.
    Kim CS; Park HS; Kawada T; Kim JH; Lim D; Hubbard NE; Kwon BS; Erickson KL; Yu R
    Int J Obes (Lond); 2006 Sep; 30(9):1347-55. PubMed ID: 16534530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocyte chemoattractant protein-1 in obesity and type 2 diabetes. Insulin sensitivity study.
    Chacón MR; Fernández-Real JM; Richart C; Megía A; Gómez JM; Miranda M; Caubet E; Pastor R; Masdevall C; Vilarrasa N; Ricard W; Vendrell J
    Obesity (Silver Spring); 2007 Mar; 15(3):664-72. PubMed ID: 17372317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C-C chemokines (monocyte chemoattractant protein-3 and RANTES).
    Ying S; Robinson DS; Meng Q; Barata LT; McEuen AR; Buckley MG; Walls AF; Askenase PW; Kay AB
    J Immunol; 1999 Oct; 163(7):3976-84. PubMed ID: 10491000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for increased expression of eotaxin and monocyte chemotactic protein-4 in atopic dermatitis.
    Taha RA; Minshall EM; Leung DY; Boguniewicz M; Luster A; Muro S; Toda M; Hamid QA
    J Allergy Clin Immunol; 2000 May; 105(5):1002-7. PubMed ID: 10808183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of omentin in adipose tissues in obese and type 2 diabetic patients].
    Cai RC; Wei L; DI JZ; Yu HY; Bao YQ; Jia WP
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(6):381-4. PubMed ID: 19567114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 11beta-hydroxysteroid dehydrogenase type 1 mRNA is increased in both visceral and subcutaneous adipose tissue of obese patients.
    Desbriere R; Vuaroqueaux V; Achard V; Boullu-Ciocca S; Labuhn M; Dutour A; Grino M
    Obesity (Silver Spring); 2006 May; 14(5):794-8. PubMed ID: 16855188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated C-reactive protein and monocyte chemoattractant protein-1 in patients with polycystic ovary syndrome.
    Hu W; Qiao J; Yang Y; Wang L; Li R
    Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):53-6. PubMed ID: 21530057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid precursor protein expression is upregulated in adipocytes in obesity.
    Lee YH; Tharp WG; Maple RL; Nair S; Permana PA; Pratley RE
    Obesity (Silver Spring); 2008 Jul; 16(7):1493-500. PubMed ID: 18483477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum adiponectin concentration in relation to body fat distribution and tissue insulin sensitivity in the glucose clamp study].
    Chen L; Xiang KS; Jia WP; Lu JX; Bao YQ; Lu HJ
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1456-9. PubMed ID: 16061021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticosteroids inhibit mRNA expression for eotaxin, eotaxin-2, and monocyte-chemotactic protein-4 in human airway inflammation with eosinophilia.
    Jahnsen FL; Haye R; Gran E; Brandtzaeg P; Johansen FE
    J Immunol; 1999 Aug; 163(3):1545-51. PubMed ID: 10415058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (Intrinsic) asthmatics.
    Ying S; Meng Q; Zeibecoglou K; Robinson DS; Macfarlane A; Humbert M; Kay AB
    J Immunol; 1999 Dec; 163(11):6321-9. PubMed ID: 10570327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of MCP-4 and high-sensitivity C-reactive protein as a marker of inflammation in obesity and chronic periodontitis.
    Pradeep AR; Kumari M; Kalra N; Priyanka N
    Cytokine; 2013 Mar; 61(3):772-7. PubMed ID: 23375121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visfatin, low-grade inflammation and body mass index (BMI).
    Samara A; Pfister M; Marie B; Visvikis-Siest S
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):568-74. PubMed ID: 18248642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum chemokine profile in patients with bullous pemphigoid.
    Nakashima H; Fujimoto M; Asashima N; Watanabe R; Kuwano Y; Yazawa N; Maruyama N; Okochi H; Kumanogoh A; Tamaki K
    Br J Dermatol; 2007 Mar; 156(3):454-9. PubMed ID: 17300233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semiquantitative analysis of intrahepatic CC-chemokine mRNas in chronic hepatitis C.
    Nischalke HD; Nattermann J; Fischer HP; Sauerbruch T; Spengler U; Dumoulin FL
    Mediators Inflamm; 2004 Dec; 13(5-6):357-9. PubMed ID: 15770052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased eotaxin-mRNA expression in non-atopic and atopic nasal polyps: comparison to RANTES and MCP-3 expression.
    Bartels J; Maune S; Meyer JE; Kulke R; Schlüter C; Röwert J; Christophers E; Schröder JM
    Rhinology; 1997 Dec; 35(4):171-4. PubMed ID: 9532637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decorin is a secreted protein associated with obesity and type 2 diabetes.
    Bolton K; Segal D; McMillan J; Jowett J; Heilbronn L; Abberton K; Zimmet P; Chisholm D; Collier G; Walder K
    Int J Obes (Lond); 2008 Jul; 32(7):1113-21. PubMed ID: 18414424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased production of proinflammatory cytokines in adipose tissue of patients with end-stage renal disease.
    Roubicek T; Bartlova M; Krajickova J; Haluzikova D; Mraz M; Lacinova Z; Kudla M; Teplan V; Haluzik M
    Nutrition; 2009; 25(7-8):762-8. PubMed ID: 19539174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased circulating CC chemokine levels in the metabolic syndrome are reduced by low-dose atorvastatin treatment: evidence from a randomized controlled trial.
    Loughrey BV; McGinty A; Young IS; McCance DR; Powell LA
    Clin Endocrinol (Oxf); 2013 Dec; 79(6):800-6. PubMed ID: 23170936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.